Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement
Pembro + CRT in HNSCC fails to deliver statistically significant event-free survival improvement
New era of early cancer detection blood tests on the horizon
Tumour-infiltrating lymphocyte treatment for advanced melanoma
Working to improve global cancer care access in low middle-income countries
Breast cancer and survivorship
Lung cancer immunotherapy adjuvant and neoadjuvant indications
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer
War in Ukraine: Global cancer aid to support refugees
War in Ukraine: The International Brain Tumour Alliance's response to aiding refugees during the crisis
Treatment with high-dose multi-agent chemotherapy for high-risk lymphoma is effective but with significant toxicity
Comment: Addition of ixazomib to pomalidomide and dexamethasone improves survival for multiple myeloma patients
EHA update: Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM